Source:http://linkedlifedata.com/resource/pubmed/id/21202553
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
Pt 6
|
| pubmed:dateCreated |
2011-1-4
|
| pubmed:abstractText |
The title adamantane derivative, C(19)H(25)NO(2), was synthesized as part of a study into potential anti-tuberculosis agents. The adamantane skeleton displays shorter than normal C-C bond lengths ranging between 1.5230?(15) and 1.5329?(16)?Å. The structure displays O-H?O hydrogen bonding and an inter-digitated layered packing structure with distinct hydro-philic and hydro-phobic regions.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:issn |
1600-5368
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
64
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
o1029
|
| pubmed:dateRevised |
2011-11-11
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
N-(2-Hydroxy-ethyl)-N-(tricyclo-[3.3.1.1]dec-2-yl)benzamide.
|
| pubmed:publicationType |
Journal Article
|